These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21339344)

  • 21. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease.
    Ikeuchi T; Hirayama S; Miida T; Fukamachi I; Tokutake T; Ebinuma H; Takubo K; Kaneko H; Kasuga K; Kakita A; Takahashi H; Bujo H; Saito Y; Nishizawa M
    Dement Geriatr Cogn Disord; 2010; 30(1):28-32. PubMed ID: 20689279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease.
    Gonzalez B; Abud EM; Abud AM; Poon WW; Gylys KH
    Neurol Clin; 2017 May; 35(2):175-190. PubMed ID: 28410655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study.
    Stewart R
    Neurology; 2001 Dec; 57(11):2149. PubMed ID: 11739854
    [No Abstract]   [Full Text] [Related]  

  • 25. [J-ADNI].
    Iwatsubo T
    Rinsho Shinkeigaku; 2010 Nov; 50(11):935. PubMed ID: 21921517
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review.
    Atiya M; Hyman BT; Albert MS; Killiany R
    Alzheimer Dis Assoc Disord; 2003; 17(3):177-95. PubMed ID: 14512832
    [No Abstract]   [Full Text] [Related]  

  • 27. Apolipoprotein e genotype modifies the phenotype of Alzheimer disease.
    Schott JM; Ridha BH; Crutch SJ; Healy DG; Uphill JB; Warrington EK; Rossor MN; Fox NC
    Arch Neurol; 2006 Jan; 63(1):155-6. PubMed ID: 16401755
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial comment--not all hypertensive subjects have similar risks for white matter lesions: influence of genetic factors.
    Leys D; Pasquier F
    Stroke; 2004 May; 35(5):1061-2. PubMed ID: 15073393
    [No Abstract]   [Full Text] [Related]  

  • 29. Summaries for patients. Genes and Alzheimer disease.
    Ann Intern Med; 2002 Aug; 137(3):I-18. PubMed ID: 12160384
    [No Abstract]   [Full Text] [Related]  

  • 30. The aging brain. Limitations in our knowledge and future approaches.
    Katzman R
    Arch Neurol; 1997 Oct; 54(10):1201-5. PubMed ID: 9341564
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetics and molecular biology.
    Cattin L; Baralle FE
    Curr Opin Lipidol; 1997 Feb; 8(1):U4-5. PubMed ID: 9127715
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuro-imaging: structural and functional imaging.
    Frisoni GB
    J Nutr Health Aging; 2009 Apr; 13(4):348-9. PubMed ID: 19300876
    [No Abstract]   [Full Text] [Related]  

  • 33. Alzheimer disease: Revising the risk of Alzheimer disease in women.
    Patel M
    Nat Rev Neurol; 2017 Oct; 13(10):575. PubMed ID: 28884752
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetics: Alzheimer risk variants affect children's brains.
    Fyfe I
    Nat Rev Neurol; 2016 Sep; 12(9):494. PubMed ID: 27469465
    [No Abstract]   [Full Text] [Related]  

  • 35. APOE genotype and brain development.
    Growdon JH; Hyman BT
    JAMA Neurol; 2014 Jan; 71(1):7-8. PubMed ID: 24276019
    [No Abstract]   [Full Text] [Related]  

  • 36. "When sex influences the brain: implications for Alzheimer disease".
    Frosch MP
    Acta Neuropathol; 2018 Dec; 136(6):855-856. PubMed ID: 30443762
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods for discerning disease-modifying effects in Alzheimer disease treatment trials.
    Kaye JA
    Arch Neurol; 2000 Mar; 57(3):312-4. PubMed ID: 10714654
    [No Abstract]   [Full Text] [Related]  

  • 38. What we have learned from the Xaliproden Sanofi-aventis trials.
    Douillet P; Orgogozo JM
    J Nutr Health Aging; 2009 Apr; 13(4):365-6. PubMed ID: 19300882
    [No Abstract]   [Full Text] [Related]  

  • 39. Longitudinal MR imaging in Alzheimer disease: a study anyone can join.
    Bizzi A
    Radiology; 2011 Mar; 258(3):657-9. PubMed ID: 21339344
    [No Abstract]   [Full Text] [Related]  

  • 40. Biomarker profiles and their relation to clinical variables in mild cognitive impairment.
    Schoonenboom SN; Visser PJ; Mulder C; Lindeboom J; Van Elk EJ; Van Kamp GJ; Scheltens PH
    Neurocase; 2005 Feb; 11(1):8-13. PubMed ID: 15804919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.